Jeffrey Unger

1.1k total citations · 1 hit paper
15 papers, 855 citations indexed

About

Jeffrey Unger is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Jeffrey Unger has authored 15 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Jeffrey Unger's work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (7 papers) and Diabetes Management and Research (7 papers). Jeffrey Unger is often cited by papers focused on Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (7 papers) and Diabetes Management and Research (7 papers). Jeffrey Unger collaborates with scholars based in United States, Germany and Denmark. Jeffrey Unger's co-authors include Julie Derving Karsbøl, Christopher Sorli, Stephen C. Bain, Thomas K. Hansen, George Tsoukas, Shin‐ichi Harashima, Christopher G. Parkin, Akiyoshi Takami, Elisabeth Souhami and Vanita R. Aroda and has published in prestigious journals such as Journal of the American College of Cardiology, Diabetes Care and The Lancet Diabetes & Endocrinology.

In The Last Decade

Jeffrey Unger

15 papers receiving 828 citations

Hit Papers

Efficacy and safety of once-weekly semaglutide monotherap... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
    2017 496 citations Christopher Sorli, Shin‐ichi Harashima et al. The Lancet Diabetes & Endocrinology profile →

Peers

Jeffrey Unger
Francis Chun Chung Chow Hong Kong
Irene Caruso Italy
Santiago Tofé Spain
Apostolos Manolopoulos United States
Juan José Gorgojo Martínez Spain
Peter Merrill United States
Meha Sharma India
Aditi Parulkar United States
Zin Zin Htike United Kingdom
R. Townsend United Kingdom
Francis Chun Chung Chow Hong Kong
Jeffrey Unger
Citations per year, relative to Jeffrey Unger Jeffrey Unger (= 1×) peers Francis Chun Chung Chow

Countries citing papers authored by Jeffrey Unger

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Unger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Unger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Unger more than expected).

Fields of papers citing papers by Jeffrey Unger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Unger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Unger. The network helps show where Jeffrey Unger may publish in the future.

Co-authorship network of co-authors of Jeffrey Unger

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Unger. A scholar is included among the top collaborators of Jeffrey Unger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Unger. Jeffrey Unger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Blevins, Thomas, Grazia Aleppo, Gregory P. Forlenza, et al.. (2022). Expert Roundtable on Continuous Glucose Monitoring. Endocrine Practice. 28(6). 622–627. 3 indexed citations
2.
3.
DeVries, J. Hans, Cyrus Desouza, Srikanth Bellary, et al.. (2018). Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme. Diabetes Obesity and Metabolism. 20(10). 2426–2434. 16 indexed citations
4.
Sorli, Christopher, Shin‐ichi Harashima, George Tsoukas, et al.. (2017). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. The Lancet Diabetes & Endocrinology. 5(4). 251–260. 496 indexed citations breakdown →
5.
Aroda, Vanita R., Jeffrey Unger, Bertrand Cariou, et al.. (2017). Semaglutide Consistently Reduces both Fasting and Postprandial Glucose Levels Across Sustain 1–5 Clinical Trials. Canadian Journal of Diabetes. 41(5). S52–S52. 1 indexed citations
6.
Osterberg, Lars, Naunihal Virdi, Yoona Kim, et al.. (2016). FIRST CLINICAL EVALUATION OF A DIGITAL HEALTH OFFERING TO OPTIMIZE TREATMENT IN PATIENTS WITH UNCONTROLLED HYPERTENSION AND TYPE 2 DIABETES. Journal of the American College of Cardiology. 67(13). 2028–2028. 8 indexed citations
7.
8.
Sorli, Christopher, George Tsoukas, Jeffrey Unger, et al.. (2016). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in subjects with type 2 diabetes (SUSTAIN 1). Diabetes Research and Clinical Practice. 120. S121–S121. 4 indexed citations
9.
Frías, Juan P., Naunihal Virdi, Praveen Raja, et al.. (2016). Abstract 17375: Evaluation of a Digital Health Offering to Optimize Blood Pressure and Lipid Control in Patients With Uncontrolled Hypertension and Type 2 Diabetes: A Pilot, Cluster Randomized Study. 134. 2 indexed citations
10.
Sorli, Christopher, Shin‐ichi Harashima, George Tsoukas, et al.. (2016). SUSTAIN 1: Efficacy and Safety of Once-Weekly Semaglutide Monotherapy vs. Placebo in Subjects with Type 2 Diabetes. Canadian Journal of Diabetes. 40(5). S6–S6. 2 indexed citations
11.
Rodbard, Helena W., Oliver Schnell, Jeffrey Unger, et al.. (2012). Use of an Automated Decision Support Tool Optimizes Clinicians’ Ability to Interpret and Appropriately Respond to Structured Self-Monitoring of Blood Glucose Data. Diabetes Care. 35(4). 693–698. 22 indexed citations
12.
Unger, Jeffrey. (2011). Insulin initiation and intensification in patients with T2DM for the primary care physician. Diabetes Metabolic Syndrome and Obesity. 4. 253–253. 18 indexed citations
13.
Unger, Jeffrey & Christopher G. Parkin. (2011). Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications. Diabetes Therapy. 2(1). 29–39. 31 indexed citations
14.
Freitag, Frederick G., Gary Finlayson, Alan M. Rapoport, et al.. (2007). Effect of Pain Intensity and Time to Administration on Responsiveness to Almotriptan: Results from AXERT ® 12.5 mg Time Versus Intensity Migraine Study (AIMS). Headache The Journal of Head and Face Pain. 47(4). 519–530. 35 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Chun Chung Chow Breakdown of academic impact, for papers by Irene Caruso Breakdown of academic impact, for papers by Santiago Tofé Breakdown of academic impact, for papers by Apostolos Manolopoulos Breakdown of academic impact, for papers by Juan José Gorgojo Martínez Breakdown of academic impact, for papers by Peter Merrill Breakdown of academic impact, for papers by Meha Sharma Breakdown of academic impact, for papers by Aditi Parulkar Breakdown of academic impact, for papers by Zin Zin Htike Breakdown of academic impact, for papers by R. Townsend
Rankless by CCL
2026